11/21
08:05 am
nams
NewAmsterdam Pharma (NASDAQ: NAMS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $36.00 price target on the stock.
Report
NewAmsterdam Pharma (NASDAQ: NAMS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $36.00 price target on the stock.
11/21
04:30 am
nams
Rating for NAMS
Low
Report
Rating for NAMS
11/21
04:30 am
nams
Rating for NAMS
Low
Report
Rating for NAMS
11/11
05:54 am
nams
Rating for NAMS
Low
Report
Rating for NAMS
11/11
05:54 am
nams
Rating for NAMS
Low
Report
Rating for NAMS
11/7
08:36 am
nams
NewAmsterdam Pharma (NASDAQ: NAMS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $36.00 price target on the stock.
Medium
Report
NewAmsterdam Pharma (NASDAQ: NAMS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $36.00 price target on the stock.
11/7
05:07 am
nams
Rating for NAMS
Low
Report
Rating for NAMS
11/7
05:07 am
nams
Rating for NAMS
Low
Report
Rating for NAMS
9/5
12:10 pm
nams
NewAmsterdam Pharma (NASDAQ: NAMS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $31.00 price target on the stock.
Low
Report
NewAmsterdam Pharma (NASDAQ: NAMS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $31.00 price target on the stock.
9/5
12:10 pm
nams
NewAmsterdam Pharma (NASDAQ: NAMS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $31.00 price target on the stock.
Low
Report
NewAmsterdam Pharma (NASDAQ: NAMS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $31.00 price target on the stock.
9/5
11:59 am
nams
Rating for NAMS
Low
Report
Rating for NAMS
9/5
11:59 am
nams
Rating for NAMS
Low
Report
Rating for NAMS
8/28
08:43 am
nams
NewAmsterdam Pharma initiated with bullish view at Needham
Medium
Report
NewAmsterdam Pharma initiated with bullish view at Needham
8/28
08:43 am
nams
NewAmsterdam Pharma initiated with bullish view at Needham
Medium
Report
NewAmsterdam Pharma initiated with bullish view at Needham
8/28
08:42 am
nams
NewAmsterdam Pharma initiated with bullish view at National Alliance
Medium
Report
NewAmsterdam Pharma initiated with bullish view at National Alliance
8/28
08:06 am
nams
NewAmsterdam Pharma (NASDAQ: NAMS) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $36.00 price target on the stock.
Medium
Report
NewAmsterdam Pharma (NASDAQ: NAMS) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $36.00 price target on the stock.
8/28
06:44 am
nams
Rating for NAMS
Low
Report
Rating for NAMS
8/28
06:44 am
nams
Rating for NAMS
Low
Report
Rating for NAMS